AmyDanaShapiroMD
Pediatric Hematology & Oncology • Indianapolis, INPediatric Coagulation Disorder Hematology
Medical Director CEO Indiana Hemophilia & Thrombosis Center
Dr. Shapiro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8326 Naab Rd
Indianapolis, IN 46260Phone+1 317-871-0000Fax+1 317-871-0010
Summary
- Amy Shapiro, MD, based in Indianapolis, IN, is a specialist in Pediatric Hematology & Oncology with a subspeciality in Pediatric Coagulation Disorder Hematology. She completed her Fellowship and Residency at the University of Colorado and is a graduate of New York University School of Medicine. Dr. Shapiro has extensive experience treating conditions like hemophilia, anemia, and sickle cell anemia. She has several publications in respected journals including Haemophilia, The Lancet, European Journal of Haematology, and Research and Practice in Thrombosis and Haemostasis. Dr. Shapiro has also been the principal investigator in numerous clinical trials focused on treatments for hemophilia and Von Willebrand Disease.
Education & Training
University of ColoradoFellowship, Pediatric Hematology/Oncology, 1983 - 1987- University of ColoradoResidency, Pediatrics, 1980 - 1983
New York University School of MedicineClass of 1980
Certifications & Licensure
IN State Medical License 1987 - 2025
CO State Medical License 1983 - 1987- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery Start of enrollment: 2001 Feb 12
- Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients Start of enrollment: 2013 May 22
- Inhibitor Development in Patients With Hemophilia A Undergoing Surgery Start of enrollment: 2011 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Pazopanib in treatment of hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding.Magdalena D Lewandowska, Shelby Gordon, Anthony Betbadal, Amy D Shapiro
Journal of Thrombosis and Haemostasis. 2024-10-23 - Prophylaxis with recombinant factor IX Fc fusion protein reduces the risk of bleeding and delays time to first spontaneous bleed event in previously untreated patients...Beatrice Nolan, Michael Recht, Pablo Rendo, Aletta Falk, Meredith Foster
European Journal of Haematology. 2024-10-01 - Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.Adam Cuker, Kaan Kavakli, Laurent Frenzel, Jiaan-Der Wang, Jan Astermark
The New England Journal of Medicine. 2024-09-26
Lectures
- B-YOND Final Results Confirm Established Safety, Sustained Efficacy, and Extended Dosing Interval for Up to 4 Years of Treatment With rFIXFc in Previously Treated Subj...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- On-Demand Treatment of Bleeding Episodes in Patients with Hereditary Factor X Deficiency Using a High-Purity Factor X Concentrate: Data from 2 Clinical Trials and a Da...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Gene Found in Indiana Amish Could Help Find Drug for LongevityNovember 27th, 2017
Amish Mutation Protects Against Diabetes and May Extend LifeNovember 23rd, 2017
Genetic Mutation in Extended Amish Family Gives Them Longer LifeNovember 18th, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
